AIC
INO icon

Ameritas Investment Company’s Inovio Pharmaceuticals INO Stock Holding History

Ameritas Investment Company’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-128
Closed -$14.2K – 1365
2021
Q1 		$14.2K Buy
+128
New +$16.8K ﹤0.01% 1409
2020
Q2 		– Sell
-85
Closed -$8K – 940
2020
Q1 		$8K Buy
+85
New +$5.24K ﹤0.01% 1263
2019
Q4 		– Sell
-9
Closed – – 1156
2019
Q3 		$0 Buy
+9
New +$274 ﹤0.01% 1646
2019
Q1 		– Sell
-15
Closed -$1K – 1394
2018
Q4 		$1K Buy
+15
New +$911 ﹤0.01% 1434

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ameritas Investment Company's INO Position: Q2 2021 in Review

Ameritas Investment Company sold out of Inovio Pharmaceuticals (INO) in Q2 2021, closing a stake of 128 shares — an estimated $14.2K sold.

Ameritas Investment Company first reported a position in INO in Q4 2018 and held it in 4 quarters. The position peaked at $14.2K in Q1 2021. 211 funds tracked by Wall St. Rank hold INO as of Q2 2021.

  • Ameritas Investment Company reported no remaining Inovio Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 128 Inovio Pharmaceuticals shares in Q2 2021, an estimated $14.2K.
  • Ameritas Investment Company first reported a position in Inovio Pharmaceuticals in Q4 2018 and held it in 4 quarters.
  • Ameritas Investment Company's Inovio Pharmaceuticals position peaked at $14.2K in Q1 2021.
  • 211 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.